NVOH — Novo Nordisk A/S (B Shares) ADRhedged
Data updated: 2026-05-21
NVOH — Novo Nordisk A/S (B Shares) ADRhedged data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Europe Health Care Equity · $3.71M AUM · 0.19% expense ratio · -46.5% 1-yr return. From SEC regulatory filings.
NVOH Fund Overview
NVOH — Novo Nordisk A/S (B Shares) ADRhedged is a US ETF managed by Precidian ETFs Trust, categorised as Europe Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Precidian ETFs Trust
- Category: Europe Health Care Equity
- Assets under management: $3.71M
- 1-year return: -46.5%
- Ticker: NVOH
- SEC CIK: 0001499655
- SEC series ID: S000058687
- Share class ID: C000192669
NVOH Holdings
Top 2 holdings of Novo Nordisk A/S (B Shares) ADRhedged by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Novo Nordisk A/S | 93.79% |
| Dreyfus Trsry Securities | 3.79% |
NVOH Portfolio Allocation
Asset-class allocation of Novo Nordisk A/S (B Shares) ADRhedged by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 93.8% |
| Cash & Equivalents | 3.8% |
NVOH Performance
Total returns for NVOH (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -23.5% |
| 1 year | -46.5% |
NVOH Risk Information
Risk metrics for NVOH, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 55.1%
NVOH Costs and Fees
NVOH costs about $19 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.19%
- Gross expense ratio: 0.19%
- Portfolio turnover: 0%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
NVOH Cashflows
Over the 12 months to 2026-03, Novo Nordisk A/S (B Shares) ADRhedged had net inflows of $4.62M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | $422.64K |
| 2026-02 | $0 |
| 2026-01 | $1.57M |
| 2025-12 | $823.48K |
| 2025-11 | $0 |
| 2025-10 | $608.29K |
NVOH Debt Constituents
No individual debt constituents are reported in Novo Nordisk A/S (B Shares) ADRhedged's latest SEC N-PORT filing.
NVOH Prospectus and SEC Filings
Official Novo Nordisk A/S (B Shares) ADRhedged filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Europe Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.